Single and dual agonists The fundamental difference between these two molecules is that semaglutide is a GLP-1 agonist, i.e., it has a strong structural similarity (95%) with this hormone and specifically activates its receptor, while tirzepatide is a dual agonist, i.e., it has a hybrid structure that allows it to activate both GLP-1 and GIP receptors (Figure 2)
Link to existing habits
Back Nathan, DM, Schreiber, E, Fogel, H, et al (Feb 1992) 'Insulinotropic action of glucagonlike peptide-I-(7-37) in diabetic and nondiabetic subjects', Journal Diabetes Care , 15/2, 270-6
If you are considering switching from tirzepatide to semaglutide or vice versa, the formulation comparison matters for continuity of your B12 support
meanwhile, the ricotta sold in most grocery stores still has 6 to 9 grams per cupplus 80% of your calcium needs for the day
GLP-1 treatments help by improving insulin sensitivity, making it easier for your body to regulate glucose